N🟁N

TORONTO, ONTARIO--(Marketwire - May 14, 2010) - ISee3D Inc. (TSX VENTURE:ICT) announced today it has retained Scarsdale Equities LLC's healthcare banking team in New York to act as ISee3D's agent to generate non-equity licensing of ISee3D's technology in advanced healthcare and medical applications worldwide.

Scarsdale Equities' healthcare banking specialists, staffed by healthcare professionals, will commence licensing efforts in healthcare and medical fields including, but not limited to, diagnostics, minimally invasive surgery, oncology, ophthalmology and dentistry. The licensing efforts will cover the application of ISee3D technologies in microscopes, colonoscopes, bronchoscopes, endoscopes, arthroscopes, and borescopes.

ISee3D CEO Dwight Romanica said "We believe our technology has the potential for broad acceptance within endoscopy and microscopy. For example, having previously developed and received FDA approval for an endoconverter system to create realistic 3D images for a surgeon to perform minimally invasive surgery, the company is focused on re-introducing the next generation HD version of the technology to endoscope manufacturers worldwide.

ISee3D has adapted its single lens, single camera technology to allow microscopes to work at up to 1,200 times magnification. This microscope initiative is market driven and serves a wide market base in the research sector, where 3D visualization provides a marked improvement over existing systems today.

We believe that the Scarsdale Equities healthcare banking team will greatly assist ISee3D in maximizing market penetration and licensing revenue in worldwide healthcare applications. Key factors in our selection included Scarsdale Equities' market intelligence, access to key potential licenses and understanding of the broad licensing opportunities.

We expect Scarsdale Equities to support the worldwide healthcare applications licensing process generating situations to out-license the technology in a timely manner," concluded Romanica.

About Scarsdale Equities

Scarsdale Equities LLC is an institutional broker-dealer located in New York City. The founding partners of Scarsdale Equities LLC are veterans of the U.S. financial services industry as investment bankers, investors and analysts. The firm's services include investment banking, institutional equity brokerage, discretionary account management, and start-up consulting and advisory services for money managers. Special focus is devoted to healthcare investment opportunities, and Scarsdale has built a healthcare group staffed by healthcare centric professionals with extensive formal education and experience in medical devices, diagnostics and therapeutics. The firm is a member of the Financial Industry Regulatory Authority (FINRA) and Securities Investor Protection Corp. (SIPC). The firm's website is located at [ www.scarsdale-equities.com ].

About ISee3D Inc.

ISee3D Inc. (TSX VENTURE:ICT) owns certain patented technology which provides for the capture of stereoscopic (3D) images through a single lens. The Company's technology has broad applications in a variety of markets including the home entertainment industry, and consumer electronics, as well as industrial and imaging devices of all types including microscopes, endoscopes as well as more sophisticated medical imaging systems.

Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as, "forward-looking statements" for purposes of the safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The company cautions readers that forward-looking statements, including without limitation those relating to the company's future operations and business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.